Table of Content


FIGURES AND TABLES
PART 1. INTRODUCTION
? Report description
? Objectives of the study
? Market segment
? Years considered for the report
? Currency
? Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
? Introduction
? Drivers
? Restraints
? Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY INDICATION
? Cancer
? Metabolic disorder
? Eye disorder
? Spinal muscular atrophy
? Others
PART 6. MARKET BREAKDOWN BY TECHNOLOGY
? Adeno virus vector
? Adeno-associated virus vector
? Lentiviral vector
? Retroviral vector
? Herpes virus vector
? Others
PART 7. MARKET BREAKDOWN BY REGION
? North America
? Europe
? Asia-Pacific
? MEA (Middle East and Africa)
? Latin America
PART 8. KEY COMPANIES
? Abeona Therapeutics Inc.
? Amgen Inc.
? Astellas Pharma Inc.
? Biogen
? bluebird bio, Inc.
? Editas Medicine Inc.
? Generation Bio Co.
? Gilead Sciences Inc.
? Novartis AG
? Orchard Therapeutics plc
? REGENXBIO Inc.
? Roche Holding AG
? Sibiono GeneTech Co., Ltd.
? UniQure N.V.
? Voyager Therapeutics Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER